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Abstract  
 Background: No local studies have been performed yet to investigate 
the influence of central or abdominal obesity on serum lipids in men having 
increased Waist Circumference (WC) compared to men with normal Waist 
Circumference values within the same BMI (Body Mass Index) category. 
Objective:To examine whether the prevalence of dyslipidemia, (defined as 
Hypercholesterolemia (Total Cholesterol level ≥240 mg/dl), high LDL-C 
level (≥160 mg/dl), low HDL-C level (<35 mg/dl), or Hypertriglyceridemia 
(TG level ≥200 mg/dl)), is higher in men having high Waist Circumference 
compared to others with normal WC values within the same BMI category. 
Methods: The study was conducted between September 2013 and July 2014. 
Eighty-eight overweight men (BMI = 25-29.9) were grouped by WC as 
follows: 28 with high values (>102 cm) and 60 with normal values (≤ 
102cm). Blood samples were drawn and assayed for total cholesterol, 
triglyceride, HDL-C, and LDL-C,at the department of Laboratory in the 
Faculty of Public Health, Lebanese University. All assays were performed by 
enzymatic colorimetric methods using Hitachi-704. 
Results: Overweight men with high WC values (according to cutoff points 
internationally adopted) were the most likely to have dyslipidemia with its 
subsequent increased health risk compared with those having normal WC 
values. 
Conclusion: we showed in this study that the prevalence of dyslipidemia in 
men with high WC values is greater compared  to those with normal WC 
values within the same BMI category. This finding leads us to the 
importance of the incorporated evaluation of WC in addition to the BMI in 
clinical practice.   
 
Keywords: Waist circumference (WC), waist to hip ratio (WHR), World 
Health Organization (WHO), cholesterylester transfer protein (CETP). 
 
Introduction  
 Obesity is defined as an excessive accumulation of energy in the 
body in the form of fat and can lead to many illnesses. Those are classified 
using three factors: fats’ amount in the body, fats’ distribution and presence 
of other risk factors. 
 To start with fat distribution, modern medicine uses the “terms 
central” and “peripheral” to describe the models of obesity(other names 
might be used such as Apple shaped obesity to describe the central obesity 
and Pear shaped to describe peripheral obesity). Other criteria like the waist 
circumference (WC), waist to hip ratio (WHR), CT scans, and magnetic 
resonance were recently added to estimate the proportion and shape of this 
European Scientific Journal October 2015 /SPECIAL/ edition Vol.2   ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
138 
distribution besides the BMI. The two models are different in the pattern of 
distribution of accumulated fat, and in the adipose modality itself. In central 
obesity, metabolically active brown adipocytes prevail over while in 
peripheral obesity less metabolically active white adipocytes form the 
majority. In addition, many studies have confirmed that there is a direct 
relation between central obesity and insulin resistance, blood lipid disorders, 
hypertension, heart disease and atherosclerosis. 
 There have been several hypotheses which attempted to explain these 
results noting that some of them are connected with the increased secretion 
of several Mediators from brown adipocytes (Leptine and TNF) or the 
increased rate of fat hydrolysis inside the brown abdominal adipocytes to the 
hyper flow of free fatty acids to the liver. These mediators may cause a 
decrease in the sensitivity of peripheral tissues to insulin, and the free fatty 
acids can lead to decrease the hepatic uptake of insulin and decrease hepatic 
glucose production. It also affects the sensitivity of peripheral tissues to 
insulin. The sharp decrease in the level of leptin following liposuction 
operations of accumulated fats in the subcutaneous tissue of the abdominal 
area supports this interpretation. We should also shed light on the role of 
some abnormalities in the gene responsible for the formation of β adrenergic 
receptors located mainly on the surface of the brown adipocytes (abdominal) 
causing obesity, specifically central obesity. 
Table 1: World Health Organization (WHO) classification of obesity according to BMI and 
WC and associated risks, as shown by the following table: 
Class BMI Kg/m2 Obesity degree Risk factor 
(WC) 
 
   <or=102cm >102cm 
Underweight <18.5  - - 
Normal 18.5-24.9  - - 
Overweight 25-29.9  increased High 
Obesity 30-34.5 I high Very high 
 35-39.9 II Very high Very high 
Severe obesity >40 III Extremely high Extremely high 
 
Assessment of central obesity 
 1. Measuring waist circumference: at the horizontal level above the 
upper iliac spine in the thinnest region of the trunk, at the end of normal 
exhalation when the patient has an empty stomach. 
 2. Measuring hip circumference: at the horizontal level and in the 
largest area of the hips and buttocks taking into consideration the ratio 
(WHR); If> 1 in men then it is a masculine (Android)  body fat distribution 
called central obesity, and according to the WHO classification : 
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Table 2 WHO classification of the highest level of WC 
Highest WC value in men 
Level 2 
(indication for intervention) 
Level 1 
(warning level) 
 
WHR>1 30≤ BMI 1>WHR≤  0.95 BMI>25  
>102cm 94 cm≤ WC 
 
 Studies also suggest that the risk of disease is lower in men with WC 
than 94 cm compared to others with WC ranges between 94 and 102 cm. 
•  Pathophysiological disorders of blood lipids in the case of insulin 
resistance (such as Central obesity): 
 
• Introduction: The cycle of the metabolic obesity is the same in the 
case of insulin resistance. 
 
 Obesity is considered another form of insulin resistance, such as high 
blood pressure, high fasting blood sugar, and blood lipid disorders (high 
triglycerides TG, and the presence of small and dense LDL particles). The 
excessive lipids in the body have several consequences on health, which are 
worse and clearer when that fat is accumulated in the abdominal area (Intra-
abdominal). 
 
Pathogenesis: shown in the four slides. 
First: (scheme 1)         
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 We notice that the insulin resistant adipocytes (especially distributed 
in the abdominal area) break down its content of triglycerides giving larger 
amounts of free fatty acids which lead in turn to increase the rate of hepatic 
uptake, and later converted into TG. 
Second: (scheme 2)    
 
 
 The existence of a high level of TG stimulate the production and 
secretion of Apo-B and VLDL and the result is an increased level of VLDL 
particles and high levels of plasma TG. 
 
Third: (scheme 3)       
 
 
 The increased level of plasma VLDL with normal levels of 
Cholesterylester transfer protein (CETP) activates the exchange between TG 
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of VLDL and the HDL cholesterol, where the molecule of VLDL gets rid of 
the TG molecule to HDL in exchange with Cholesterylester molecules. This 
leads to two outcomes: (1) the remnants of VLDL rich in cholesterol 
predispose to the occurrence of atherosclerosis.  (2) HDL molecule rich with 
TG and poor with cholesterol submit additional TG hydrolysis by liver 
lipase, leading to its separation from surfactant protein (ApoA-I) so it is 
filtered faster in the plasma, and one of this filtration has place in the 
kidneys. This leads to a decline in the proportion of HDL-C and the amount 
of ApoA-I and the number of particles of HDL. 
The last scheme :( scheme 4) 
 
  
This slide shows a similar phenomenon leading to the formation of 
small and dense LDL particles and the presence of high levels of TG within 
the VLDL predispose the transfer of TG to inside the LDL and the exit of 
cholesterolester out of them (in the presence of CETP). The LDL rich in TG 
will be exposed later to several hydration reactions by hepatic lipase (HL) or 
(LPL), leading to the formation of small dense LDL particles poor in 
cholesterol or fat in general. 
 
Materials & methods 
 This research was conducted on a sample of 88 overweight men with 
overweight (25<BMI≤30), apparently being healthy who referred to the 
medical analyses center in the Faculty of Public Health, Lebanese 
University, for several chief complaints that do not affect the results, 
between the month of September 2013 and July of 2014.Results were 
classified according to waist circumference WC where the number of men 
with high WC (greater than 102 cm) is 28 men, and the number of men with 
normal WC (less than or equal to 102 cm) is 60 men described far ahead. 
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 Blood samples withdrawal in dry tubes after a fasting period of at 
least 12 hours, taking into consideration all the recommendations of the 
NCEP Adult Treatment Panel III, 2001 then serum analysis for blood sugar, 
TG, total cholesterol, LDL-C, HDL-C, uric acid, blood urea, creatinine, and 
albumin. Assays were done by color enzymatic colorimetric assay device 
(Hitachi 704). 
Test Target   
Total cholesterol <200mg/dl 200-239 ≥240 
LDL-C <130mg/dl 130-159 ≥160 
HDL-C >35   
TG >160 161-200 >200 
Table (3) the used criteria (according to the recommendations of the NCEP) 
 
 As for the uric acid, urea, albumin, creatinine, we used a special 
laboratory measurements of the Central sympathy marginal standards. 
 And the number 102 cm was considered a Cutoff Point for waist 
circumference knowing that it is considered as high risk if the patient had a 
higher value. 
 
Results 
 After collecting the results of the study and dividing them into two 
groups depending on the measurement of WC, the statistical results appeared 
as follows: 
• Prevalence: 
WC High total 
cholesterol(≥240mg/dl) 
Low HDL-C 
(<35mg/dl) 
High LDL-C 
(≥160mg/dl) 
High TG 
(≥200mg/dl) 
Normal(≤102cm) 17.24% 24.13% 15.5% 24.13% 
High 
risk(>102cm 
42.3% 46.15% 38.4% 46.2% 
Table (4) the spread of blood lipid disorders rate with the WC 
 
Chart (1) the prevalence of blood lipid disorders in high WC men compared to normal 
WC in Overweight BMI category 
According to the mean value of the results: 
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WC Total cholesterol 
(mg/dl) 
HDL-C (mg/dl) LDL-C (mg/dl) TG (mg/dl) 
Normal 
(≤102cm) 
*41.4±204.73 *10.3±47.25 *39.2±129.24 *67.6±164.49 
High risk 
(<102cm) 
*38.8±233.25 *7±41.62 *36.2±152.7 *77.9±212.49 
*Mean ± SD 
 
Table (5) changing levels of serological lipids with the WC 
 
Chart (2) alterations serum lipid levels with the WC. 
 
Interpretation of the results: 
 The previous two tables show that the prevalence of disorders in 
blood lipid disorders or Dyslipidemia (known as high blood cholesterol (TC 
level ≥ 240 mg / dl), high LDL-C serum level (≥160 mg / dl), low serum 
level HDL-C (<40 mg / dl), or high blood TG (≥240 mg / dl)) were higher in 
men with waist circumference (WC >102 cm) than in the other category 
(WC ≤ 102 cm); the average lipid profile was obviously abnormal showing a 
clear difference in numbers between the two categories. 
 By applying statistical Paired t-test on the previous results, we have 
in the table (5) a difference that is considered to be statistically significant in 
lipid serological levels between the two groups: total cholesterol was P = 
0.0001, the HDL- C was P = 0.0197, the LDL-C was P = 0.0002, the TG was 
P = 0.039. 
 This indicates that the risk is higher in people with central obesity 
(i.e., waist circumference is greater by 102 cm) than the other group (i.e., 
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waist circumference is less or equal to 102 cm) recording the obvious 
difference and meaningful numbers in serum levels of lipids and 
lipoproteins. 
 
Comparison studies 
 A large study conducted by the endocrinology and metabolism 
department of faculties of medicine and health and physical education at 
Queen’s University, Ontario, Canada, and published in 2002. 
Results of the study: 
BMI  
Overweight category  
WC high 
)n=851( 
WC normal 
)n=2230( 
 
The average serology values 
213.7±42.7* 203.3±40* Total cholesterol (mg/dl) 
138.5±36.2* 130.5±34.6* LDL-C (mg/dl( 
42.0±11.2* 44.9±12.9* HDL-C (mg/dl( 
194.5±124.8* 155.4±108* TG (mg/dl) 
Prevalence% , 
26.2 17.2 total high cholesterol 
27.2 19.3 LDL-C high 
49 35.5 HDL-C low 
36.3 21.7 TG high 
Table (6): comparison of metabolic variables and the prevalence of blood lipid disorders 
among men with normal WC vs. WC in the Overweight BMI Category 
 
 Discussion of the study results and comparing them to the results 
obtained: 
The findings of the universal study carried out by a large number of 
men and women have shown that people with central obesity among the 
three categories of the BMI ratio were diagnosed with high blood pressure, 
diabetes type II, and blood lipid profile disorders higher compared to normal 
numbers for WC. The differences between the serum levels of lipids and 
lipoproteins between the two categories of the WC were clear, where the P 
Value was less than 0.05. Comparing these results to the results of our study, 
we found that the numbers we have obtained regarding the category 
Overweight BMI was convergent with those of the universal study. 
 
Conclusion and Recommendations 
 Previous study concluded that central obesity has an important and 
independent role in the growing proportion of the health risks such as blood 
lipid disorder regardless of the degree of obesity. 
 And as a result of this research, the National Institutes of Health are 
recommended with the following: 
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1. Assess central obesity by measurement of waist circumference WC along 
with BMI and consider it as an Independent High-risk Factor. 
2. Use Cutoff Points adopted by the NIH (National Institutes of Health). 
3. Preserve a normal WC and try to have an optimal one to avoid all the 
health risks associated with abdominal obesity and exercise regularly 
knowing that it has an important role in getting rid of abdominal obesity. 
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